2 July 2021 - Deborah Wilkes
Premium
Activist investor Elliott Investment Management is urging GlaxoSmithKline (GSK) to consider selling its Consumer Healthcare business rather than going ahead with the proposed separation.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.